Equities

Allergy Therapeutics PLC

Allergy Therapeutics PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)18.45
  • Today's Change-0.050 / -0.27%
  • Shares traded25.00k
  • 1 Year change-51.13%
  • Beta1.3787
Data delayed at least 20 minutes, as of Sep 27 2022 12:45 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

As of last trade, Allergy Therapeutics PLC (AGY:LSE) traded at 18.45, 15.31% above the 52 week low of 16.00 set on Jul 15, 2022.
52-week range
Today
16.00Jul 15 202240.50Oct 25 2021
Markit short selling activity
Low
Med
High
Open18.50
High19.75
Low19.75
Bid18.00
Offer19.00
Previous close18.50
Average volume23.02k
Shares outstanding644.10m
Free float100.19m
P/E (TTM)--
Market cap119.16m GBP
EPS (TTM)-0.0091
GBP
Data delayed at least 20 minutes, as of Sep 27 2022 12:45 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Allergy Therapeutics PLC shares was Hold at 13.00 on 25 Sep 2019Read the full article
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.